The Female Health Company (FHC) to Expand Manufacturing Capacity for FC2 Female Condom By 150%
More News related to FHC
- The Female Health Company (FHC) to Expand Manufacturing Capacity for FC2 Female Condom By 150%
- The Female Health Company (FHC) Expands Buyback Program to 3M Shares
- Female Health (FHC) Raises Buyback Plan to 2M Shares
- The Female Health Company (FHC) Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
More News related to Corporate News
- S&P Announces Change to US Index: TSRA for FIF
- RealNetworks (RNWK) and MTV Networks (VIA-B) to Split Off Joint Venture Rhapsody
- Watts Water (WTS) Board Approves Restructuring Program; Shutting Down 3 Plants, Cutting 95 Jobs
- Transcept Pharmaceuticals (TSPT) Granted U.S. Patent Covering Intermezzo Formulation
- AAR (AIR) Predicts Impact of Mesa's Bankruptcy on Q3 Results
The Female Health Company (AMEX: FHC) announced plans to install six more production lines for its FC2 Female Condom(TM), increasing its annualized FC2 production capacity in Malaysia from 30 million units to approximately 75-80 million units.
Currently, The Female Health Company is manufacturing its second-generation product, FC2, on four production lines in Malaysia. The Company, in conjunction with its Indian partner, HLL Lifecare Limited, currently produces FC2 on a fifth production line located in Kochi, India.
Mike Pope, V.P., U.K. and Malaysian operations indicated: "The Malaysian production expansion will bring the total FC2 female condom manufacturing capacity to an annualized rate of approximately 85 million units by early in the fourth quarter of calendar year 2009."
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
